274
Views
6
CrossRef citations to date
0
Altmetric
Review

Switching to biosimilars in the treatment of rheumatic diseases

ORCID Icon, , &
Pages 557-571 | Received 12 Mar 2018, Accepted 14 Jun 2018, Published online: 13 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Abdulaali R. Almutairi, Ali M. Al-Samil, Abdulaziz Alsayyari, Consuela Cheriece Yousef, Mansoor Ahmed Khan, Hani S. Alhamdan & Ahmed Al-Jedai. (2023) The landscape of biosimilars in Saudi Arabia: preparing for the next decade. Expert Opinion on Biological Therapy 23:8, pages 679-688.
Read now
Sanjiv S. Agarwala, Ulrich Nagl, Xinghua Guo, Anne Bellon, Jens Heyn, Miryana Dimova-Dobreva, Yu-Ming Shen, Gregor Schaffar, Martin Humphrey, Nicola Mathieson, Natalia Koptelova & Sreekanth Gattu. (2022) A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006). Current Medical Research and Opinion 38:6, pages 999-1009.
Read now
Ju-Yang Jung, Ji-Won Kim, Hyoun-Ah Kim & Chang-Hee Suh. (2019) Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 19:10, pages 979-986.
Read now
Christopher J. Edwards, Jana Hercogová, Helene Albrand & Aurelian Amiot. (2019) Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases. Expert Opinion on Biological Therapy 19:10, pages 1001-1014.
Read now

Articles from other publishers (2)

Sherin Ismail, Laila Abu Esba, Mansoor Khan, Hana Al-Abdulkarim, Hind Modimagh & Consuela Yousef. (2022) An Institutional Guide for Formulary Decisions of Biosimilars. Hospital Pharmacy 58:1, pages 38-48.
Crossref
Bruna de Oliveira Ascef, Renan Gonçalves Leonel da Silva, Haliton Alves de Oliveira Júnior & Patrícia Coelho De Soárez. (2019) Intercambialidade e substituição de biossimilares: seria a avaliação de tecnologias em saúde (ATS) um instrumento para tomada de decisão?. Cadernos de Saúde Pública 35:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.